SCHEMBL1906271

SCHEMBL1906271

Cc1c(I)cnn1-c1ccccn1.Cc1ccnn1-c1ccccn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXTR P30559 4/20 0.40
AVPR1A P37288 2/20 0.40
KDM5A P29375 2/20 0.40
KDM4C Q9H3R0 2/20 0.40
KDM5B Q9UGL1 2/20 0.40
CYP17A1 P05093 2/20 0.39
HPGD P15428 2/20 0.39
RAB9A P51151 2/20 0.39
CYP1A2 P05177 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
GFER P55789 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
DPP4 P27487 1/20 0.36
MAPT P10636 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
FPR1 P21462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1908345 0.91 RAB9A (0.44) KDM5AKDM4CKDM5BCYP17A1HPGD
SCHEMBL1905339 0.84 KDM5A (0.50) OXTRAVPR1AKDM5AKDM4CKDM5B
SCHEMBL12922843 0.75 CYP17A1 (0.49) KDM5AKDM4CKDM5BCYP17A1HPGD
SCHEMBL1906551 0.73 LMNA (0.32)
SCHEMBL12923215 0.70 GFER (0.48) KDM5AKDM4CKDM5BCYP17A1HPGD
SCHEMBL31596129 0.69 HPGD (0.44) KDM5AKDM4CKDM5BCYP17A1HPGD
SCHEMBL122538 0.69 HPGD (0.47) KDM5AKDM4CKDM5BCYP17A1HPGD
SCHEMBL122430 0.69 HPGD (0.44) KDM5AKDM4CKDM5BCYP17A1HPGD
SCHEMBL3517338 0.68 NPC1 (0.55) KDM5AKDM4CKDM5BHPGDRAB9A
SCHEMBL1574919 0.68 MAPK1 (0.63) KDM5AKDM4CKDM5BHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2320907-A1 THERAPEUTIC COMPOUNDS Merck & Co., Inc. (US) 2011-05-18 EP disclosed
WO-2010017047-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2010-02-11 WO disclosed